SI20150A - Direktno stisljivi matriks za nadzorovano sproščanje celodnevne doze klaritromicina - Google Patents

Direktno stisljivi matriks za nadzorovano sproščanje celodnevne doze klaritromicina Download PDF

Info

Publication number
SI20150A
SI20150A SI9900039A SI9900039A SI20150A SI 20150 A SI20150 A SI 20150A SI 9900039 A SI9900039 A SI 9900039A SI 9900039 A SI9900039 A SI 9900039A SI 20150 A SI20150 A SI 20150A
Authority
SI
Slovenia
Prior art keywords
pharmaceutical formulation
formulation according
clarithromycin
tablet
matrix
Prior art date
Application number
SI9900039A
Other languages
English (en)
Slovenian (sl)
Inventor
TEMELJOTOV Darja FER�EJ
Milojka Mohar
Mateja Salobir
Ljubomira Barbara Rebi�
Marko Opresnik
Original Assignee
Lek, Tovarna Farmacevtskih In
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lek, Tovarna Farmacevtskih In filed Critical Lek, Tovarna Farmacevtskih In
Priority to SI9900039A priority Critical patent/SI20150A/sl
Priority to TR2001/02396T priority patent/TR200102396T2/xx
Priority to DK00905514T priority patent/DK1150686T3/da
Priority to AT00905514T priority patent/ATE286736T1/de
Priority to YUP-592/01A priority patent/RS50298B/sr
Priority to ES00905514T priority patent/ES2235834T3/es
Priority to CZ20012964A priority patent/CZ302781B6/cs
Priority to EP00905514A priority patent/EP1150686B1/en
Priority to RU2001125667A priority patent/RU2237480C2/ru
Priority to EEP200100433A priority patent/EE05422B1/xx
Priority to DE60017361T priority patent/DE60017361T2/de
Priority to PL350419A priority patent/PL196665B1/pl
Priority to SI200030647T priority patent/SI1150686T1/xx
Priority to UA2001096230A priority patent/UA74778C2/uk
Priority to PT00905514T priority patent/PT1150686E/pt
Priority to HU0105481A priority patent/HUP0105481A3/hu
Priority to AU27049/00A priority patent/AU776912B2/en
Priority to PCT/SI2000/000002 priority patent/WO2000048607A1/en
Priority to SK1197-2001A priority patent/SK287525B6/sk
Publication of SI20150A publication Critical patent/SI20150A/sl
Priority to HR20010684A priority patent/HRP20010684B1/xx
Priority to BG105914A priority patent/BG65324B1/bg
Priority to CY20051100330T priority patent/CY1107454T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SI9900039A 1999-02-19 1999-02-19 Direktno stisljivi matriks za nadzorovano sproščanje celodnevne doze klaritromicina SI20150A (sl)

Priority Applications (22)

Application Number Priority Date Filing Date Title
SI9900039A SI20150A (sl) 1999-02-19 1999-02-19 Direktno stisljivi matriks za nadzorovano sproščanje celodnevne doze klaritromicina
PL350419A PL196665B1 (pl) 1999-02-19 2000-02-17 Preparat o kontrolowanym uwalnianiu zawierający klarytromycynę i sposób jego wytwarzania
SI200030647T SI1150686T1 (en) 1999-02-19 2000-02-17 Directly compressible matrix for controlled release of single daily doses of clarithromycin
DK00905514T DK1150686T3 (da) 1999-02-19 2000-02-17 Direkte komprimerbar matrix til kontrolleret frigivelse af daglige enkeltdoser af clarithromycin
YUP-592/01A RS50298B (sr) 1999-02-19 2000-02-17 Direktno kompresibilna matrica za kontrolisano oslobađanje pojedinačnih dnevnih doza klaritromicina
ES00905514T ES2235834T3 (es) 1999-02-19 2000-02-17 Matriz directamente comprimible para la liberacion controlada de dosis diarias unicas de claritromicina.
CZ20012964A CZ302781B6 (cs) 1999-02-19 2000-02-17 Farmaceutický prostredek pro jednorázovou denní dávku s rízeným uvolnováním úcinné látky, zpusob prípravy tohoto farmaceutického prostredku a použití tohoto farmaceutického prostredku pri lécení a profylaxi
EP00905514A EP1150686B1 (en) 1999-02-19 2000-02-17 Directly compressible matrix for controlled release of single daily doses of clarithromycin
RU2001125667A RU2237480C2 (ru) 1999-02-19 2000-02-17 Непосредственно прессуемая матрица для регулируемого высвобождения однократных ежедневных доз кларитромицина
UA2001096230A UA74778C2 (en) 1999-02-19 2000-02-17 Pharmaceutical formulation for controlled release of clarithromycin
DE60017361T DE60017361T2 (de) 1999-02-19 2000-02-17 Direktverpressbare matrix zur kontrollierten abgabe von einmaltäglichen dosen von clarithromycin
TR2001/02396T TR200102396T2 (tr) 1999-02-19 2000-02-17 Klaritromisinin günlük tek dozunun kontrollü olarak verilmesi.
AT00905514T ATE286736T1 (de) 1999-02-19 2000-02-17 Direktverpressbare matrix zur kontrollierten abgabe von einmaltäglichen dosen von clarithromycin
EEP200100433A EE05422B1 (et) 1999-02-19 2000-02-17 Klaritromtsiini, rasv- ja hdrofiilse komponendi segu sisaldav farmatseutiline preparaat, meetod selle valmistamiseks ning kasutamine
PT00905514T PT1150686E (pt) 1999-02-19 2000-02-17 Matriz directamente compressivel para libertacao controlada de doses diarias unitarias de claritromicina
HU0105481A HUP0105481A3 (en) 1999-02-19 2000-02-17 Pharmaceutical compositions containing clarithromycin and process for their preparation and their use
AU27049/00A AU776912B2 (en) 1999-02-19 2000-02-17 Directly compressible matrix for controlled release of single daily doses of clarithromycin
PCT/SI2000/000002 WO2000048607A1 (en) 1999-02-19 2000-02-17 Directly compressible matrix for controlled release of single daily doses of clarithromycin
SK1197-2001A SK287525B6 (sk) 1999-02-19 2000-02-17 Farmaceutická formulácia s riadeným uvoľňovaním
HR20010684A HRP20010684B1 (en) 1999-02-19 2001-09-18 Directly compressible matrix for controlled release of single daily doses of clarithromycin
BG105914A BG65324B1 (bg) 1999-02-19 2001-09-19 Фармацевтична форма за еднократно дневно перорално приложение на кларитромицин
CY20051100330T CY1107454T1 (el) 1999-02-19 2005-03-10 Μητρα αμεσης συμπιεσης για ελεγχομενη απελευθερωση ημepησιων μονοδοσεων της κλαριθρομυκινης

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SI9900039A SI20150A (sl) 1999-02-19 1999-02-19 Direktno stisljivi matriks za nadzorovano sproščanje celodnevne doze klaritromicina

Publications (1)

Publication Number Publication Date
SI20150A true SI20150A (sl) 2000-08-31

Family

ID=20432410

Family Applications (2)

Application Number Title Priority Date Filing Date
SI9900039A SI20150A (sl) 1999-02-19 1999-02-19 Direktno stisljivi matriks za nadzorovano sproščanje celodnevne doze klaritromicina
SI200030647T SI1150686T1 (en) 1999-02-19 2000-02-17 Directly compressible matrix for controlled release of single daily doses of clarithromycin

Family Applications After (1)

Application Number Title Priority Date Filing Date
SI200030647T SI1150686T1 (en) 1999-02-19 2000-02-17 Directly compressible matrix for controlled release of single daily doses of clarithromycin

Country Status (21)

Country Link
EP (1) EP1150686B1 (ru)
AT (1) ATE286736T1 (ru)
AU (1) AU776912B2 (ru)
BG (1) BG65324B1 (ru)
CY (1) CY1107454T1 (ru)
CZ (1) CZ302781B6 (ru)
DE (1) DE60017361T2 (ru)
DK (1) DK1150686T3 (ru)
EE (1) EE05422B1 (ru)
ES (1) ES2235834T3 (ru)
HR (1) HRP20010684B1 (ru)
HU (1) HUP0105481A3 (ru)
PL (1) PL196665B1 (ru)
PT (1) PT1150686E (ru)
RS (1) RS50298B (ru)
RU (1) RU2237480C2 (ru)
SI (2) SI20150A (ru)
SK (1) SK287525B6 (ru)
TR (1) TR200102396T2 (ru)
UA (1) UA74778C2 (ru)
WO (1) WO2000048607A1 (ru)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR200000054A2 (tr) * 2000-01-05 2001-08-21 Sanovel İlaç San. Ve Ti̇c. Anoni̇m Şi̇rketi̇ Klaritromisin içeren sürekli salım sağlayan tablet formülasyonları.
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
IN192748B (ru) * 2000-08-29 2004-05-15 Ranbaxy Lab Ltd
US20020068078A1 (en) 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
US6673369B2 (en) 2001-08-29 2004-01-06 Ranbaxy Laboratories Limited Controlled release formulation
US6642276B2 (en) * 2001-10-01 2003-11-04 M/S Ind-Swift Limited Controlled release macrolide pharmaceutical formulations
SE0103369D0 (sv) * 2001-10-09 2001-10-09 Astrazeneca Ab Pharmaceutical formulation
WO2003037304A1 (en) 2001-11-02 2003-05-08 Wockhardt Limited Controlled release compositions for macrolide antimicrobial agents
BR0308989A (pt) * 2002-04-03 2005-01-04 Ranbaxy Lab Ltd Formulações de claritromicina com biodisponibilidade aperfeiçoada e processo de preparação das mesmas
US20060083759A1 (en) * 2002-07-17 2006-04-20 Aleksander Resman Stabilization of the profile of release of active substances from a formulation
NZ537543A (en) * 2002-07-29 2007-08-31 Alza Corp Formulations and high dose osmotic dosage forms for controlled delivery of topiramate
US20050232995A1 (en) 2002-07-29 2005-10-20 Yam Nyomi V Methods and dosage forms for controlled delivery of paliperidone and risperidone
CA2535398C (en) 2003-08-12 2013-11-12 Advancis Pharmaceuticals Corporation Antibiotic product, use and formulation thereof
WO2005023221A1 (en) * 2003-09-05 2005-03-17 Ranbaxy Laboratories Limited Clarithromycin formulations having improved biovailability
US7943585B2 (en) * 2003-12-22 2011-05-17 Sandoz, Inc. Extended release antibiotic composition
BRPI0508743A (pt) * 2004-03-24 2008-01-22 Lupin Ltd composição farmacêutica com uma liberação estendida de eritromicina ou um derivado da mesma, método para o uso de uma composição farmacêutica e processo para a preparação de uma composição farmacêutica
EP2283824B1 (en) 2009-07-30 2017-04-19 Special Products Line S.p.A. Compositions and formulations based on swellable matrices for sustained release of poorly soluble drugs such as clarithromycin

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4331803A (en) * 1980-06-04 1982-05-25 Taisho Pharmaceutical Co., Ltd. Novel erythromycin compounds
JPS60163823A (ja) * 1984-02-03 1985-08-26 Taisho Pharmaceut Co Ltd 経口投与製剤
JPS60214796A (ja) * 1984-04-06 1985-10-28 Taisho Pharmaceut Co Ltd ６−０−メチルエリスロマイシン類の製法
JPS63188621A (ja) * 1987-01-30 1988-08-04 Taisho Pharmaceut Co Ltd 矯味経口製剤
US4808411A (en) * 1987-06-05 1989-02-28 Abbott Laboratories Antibiotic-polymer compositions
IL87219A0 (en) * 1987-08-07 1988-12-30 Abbott Lab Erythromycin formulations for oral administration
JP2553882B2 (ja) * 1987-08-08 1996-11-13 富士写真光機株式会社 走査結像光学系
US5599556A (en) * 1991-12-31 1997-02-04 Abbott Laboratories Prolamine coatings for taste masking
MX9603480A (es) * 1994-02-16 1997-12-31 Abbott Lab Procedimiento para preparar formulaciones farmaceuticas en particulas finas.

Also Published As

Publication number Publication date
HRP20010684B1 (en) 2011-01-31
EP1150686B1 (en) 2005-01-12
DK1150686T3 (da) 2005-04-04
HUP0105481A3 (en) 2003-04-28
UA74778C2 (en) 2006-02-15
RU2237480C2 (ru) 2004-10-10
PL350419A1 (en) 2002-12-16
SK11972001A3 (sk) 2002-02-05
AU2704900A (en) 2000-09-04
SK287525B6 (sk) 2011-01-04
AU776912B2 (en) 2004-09-23
EE05422B1 (et) 2011-06-15
HUP0105481A2 (hu) 2002-05-29
WO2000048607A1 (en) 2000-08-24
TR200102396T2 (tr) 2002-01-21
EE200100433A (et) 2002-12-16
RS50298B (sr) 2009-09-08
HRP20010684A2 (en) 2002-10-31
PL196665B1 (pl) 2008-01-31
ATE286736T1 (de) 2005-01-15
EP1150686A1 (en) 2001-11-07
ES2235834T3 (es) 2005-07-16
DE60017361D1 (de) 2005-02-17
CZ302781B6 (cs) 2011-11-02
PT1150686E (pt) 2005-05-31
DE60017361T2 (de) 2005-12-22
BG105914A (bg) 2002-05-31
YU59201A (sh) 2004-07-15
CZ20012964A3 (cs) 2002-01-16
CY1107454T1 (el) 2012-12-19
BG65324B1 (bg) 2008-02-29
SI1150686T1 (en) 2005-06-30

Similar Documents

Publication Publication Date Title
SI20150A (sl) Direktno stisljivi matriks za nadzorovano sproščanje celodnevne doze klaritromicina
DE69924283T2 (de) DOSIERUNGSFORM MIT KONTROLLIERTER FREIGABE, DIE ZOLPIDEM ODER EIN SALZ DAVON ENTHäLT
JP2001172201A (ja) 経口投与形のための味をマスキングするコーティングとしてのフィルム被覆の使用、経口投与形及びその製造法
EP1722821B1 (en) Composition for oral administration of tamsulosin hydrochloride and controlled release granule formulation comprising same
Kranz et al. Drug release from MCC-and carrageenan-based pellets: experiment and theory
NZ205894A (en) Pharmaceutical compositions containing mopidamol(2,6-bis(diethanolamino)-4-piperidino-pyrimido(5,4-d)pyrimidine)
JPH10502390A (ja) 医薬品用の徐放性マトリックス
CA2352496A1 (en) Oral solid pharmaceutical formulations with ph-dependent multiphasic release
EP2415460A1 (de) Orale Darreichungsform von Pregabalin
KR20050005437A (ko) 아목시실린의 변형 방출을 위한 마이크로캡슐 수성 현탁액형태의 경구 제약학적 제제
KR20000071245A (ko) 활성 물질의 방출이 조절되는 진통제
US8642078B2 (en) Coated formulations for tolterodine
JP3833314B2 (ja) 発泡性組成物およびその製造方法
JP2002332226A (ja) 薬物顆粒の製造方法、および薬物顆粒、ならびにそれを用いた医薬製剤
US4832955A (en) Controlled release potassium chloride composition
JP3466921B2 (ja) 味マスキング医薬製剤
EP3892263A1 (en) Oral dosage form
WO1999001120A1 (en) Solubilized sertraline compositions
MXPA05004648A (es) Comprimidos orales de liberacion extendida y procedimientos de preparacion y uso de los mismos.
EP1443910A1 (en) Controlled release compositions for macrolide antimicrobial agents
KR102246658B1 (ko) 탐수로신 염산염 함유 서방성 과립을 포함하는 경구용 약제학적 제제
SI20244A (sl) Granulacija v talini
KR101799321B1 (ko) 에페리손 서방성 미립구와 아세클로페낙 복합제제
SI21300A (sl) Farmacevtske formulacije z alginati
KR101812520B1 (ko) 개선된 약제학적 스타터 펠렛

Legal Events

Date Code Title Description
IF Valid on the event date
KO00 Lapse of patent

Effective date: 20061013